Lonhala Magnair Kit

Active Ingredient(s): Glycopyrrolate
FDA Approved: * December 5, 2017
Pharm Company: * SUNOVION RESP
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Lonhala Magnair Kit Overview

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has no to few central effects. It is available in by mouth, intravenous, and inhalated forms. It is a synthetic quaternary amine. It was developed by Sosei and licensed to Novartis in 2005. The cation, which is the active moiety, is called glycopyrronium (INN)[1] or glycopyrrolate (USAN). In June 2018, glycopyrronium was approved by ...

Read more Lonhala Magnair Kit Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glycopyrrolate

Recent Lonhala Magnair Kit Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Glycopyrrolate

Injection: 0.2mg/ml
Powder: 15.6mcg, 15.6mcg/inh
Solution: 0.2mg/ml, 0.2mg/ml (0.2mg/ml), 0.4mg/2ml (0.2mg/ml), 1mg/5ml, 25mcg/ml
Tablet: 1.5mg, 1mg, 2mg

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Glycopyrrolate or a similar ingredient: (10 results)

CUVPOSA Glycopyrrolate
GLYCOPYRROLATE 12 discussions
GLYRX-PF Glycopyrrolate
ROBINUL Glycopyrrolate1 discussion
ROBINUL INJECTABLE Glycopyrrolate
SEEBRI NEOHALER Glycopyrrolate
BEVESPI AEROSPHERE Glycopyrrolate + Formoterol Fumarate1 discussion
GLYCOPYRROLATE + FORMOTEROL FUMARATE
INDACATEROL + GLYCOPYRROLATE
UTIBRON NEOHALER Indacaterol + Glycopyrrolate